Concord Medical Co Ltd(TW:6518)
NT$29.85-0.15 (-0.50%)
TW:6518
Concord Medical Co Ltd financials statements
NT$29.85
At close:-0.15 (-0.50%)
Concord Medical Co Ltd (6518) Income Statement
Concord Medical Co Ltd Income Statement
Last quarter (Q2 2026), Concord Medical Co Ltd's total revenue was NT$522.93M, an increase of 20.67% from the same quarter last year. In Q2, Concord Medical Co Ltd's net income was NT$47.48M. See Concord Medical Co Ltd’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 964.35M | NT$ 889.85M | NT$ 833.20M | NT$ 889.21M | NT$ 738.99M | |
| NT$ 133.96M | NT$ 109.62M | NT$ 102.15M | NT$ 109.10M | NT$ 68.49M | |
| NT$ 61.19M | NT$ 47.79M | NT$ 47.41M | NT$ 45.00M | NT$ 32.86M | |
| Depreciation and Amortization | NT$ 84.97M | NT$ 86.22M | NT$ 79.43M | NT$ 76.42M | NT$ 96.59M |
| NT$ 157.74M | NT$ 152.22M | NT$ 137.47M | NT$ 143.47M | NT$ 144.16M | |
| NT$ 72.78M | NT$ 61.83M | NT$ 54.91M | NT$ 64.78M | NT$ 37.47M | |
| NT$ 10.06M | NT$ 1.64M | NT$ -215.00K | NT$ -560.00K | NT$ 5.32M | |
| NT$ 82.83M | NT$ 62.45M | NT$ 54.53M | NT$ 64.22M | NT$ 42.79M | |
| NT$ 67.93M | NT$ 49.57M | NT$ 42.74M | NT$ 50.66M | NT$ 34.40M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 2.02 | NT$ 1.49 | NT$ 1.28 | NT$ 1.52 | NT$ 1.37 |
| Diluted EPS | NT$ 2.02 | NT$ 1.48 | NT$ 1.28 | NT$ 1.52 | NT$ 1.37 |
| Weighted Average Shares Outstanding | 33.63M | 33.33M | 33.39M | 33.33M | 25.05M |
| Weighted Average Shares Outstanding (Diluted) | 33.63M | 33.43M | 33.45M | 33.33M | 25.10M |
Currency in TWD
